Trialect

Active

Pfizer Independent Medical Education Request for Proposals (RFP): Early Diagnosis Improvement of Chlamydia Infections

Pfizer Inc.

This competitive program seeks to support health care professionals medical education to improve early diagnosis of chlamydia infections.

Potential applicants are encouraged to develop educational programs to identify and address the educational needs, barriers, and gaps for early diagnosis of chlamydia.

Under this RFP, grants will be offered to support evidence-based programs, with a high reach potential, aiming to improve routine screening practices, appropriate diagnostic methods for chlamydia, use of latest guidelines, and best practices for early diagnosis of chlamydia infections. Educational programs with a focus on addressing specific challenges faced by marginalized populations are also within scope.

Independent medical educational proposals may include live and/or virtual & theoretical and/or practical activities, educational public health interventions, enduring courses, workshops, modules, handson-training, educational resources and tools, technology platforms and social media, or any combination of traditional and/or innovative formats.

Application submission deadline: October 7, 2024

Specialties

Curriculum Development

Medical - Clinical Science

Medical

Eligibility Requirements

Geographic Scope/Location of Project: • Global, prioritizing cross-regional and international reach

• The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; health care institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to health care professional education and/or healthcare improvement. • Proposals with a coverage of more than 1 country, or with a regional or international reach are highly recommended. • Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society). • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project. • The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator). • The project/program lead must be an employee or contractor of the requesting organization. • Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.